iTeos Therapeutics, Inc. Insider Transactions
iTeos Therapeutics, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Gall Matthew
CFO |
Buy | 5,000 @ $7.73 | $38,635 | 65,429 | 11/19/2024 | 11/19/2024 | |
|
RA CAPITAL MANAGEMENT, L.P.
Other: Former 10% Owner |
Buy | 5,714,285 @ $0.00 | $5,714 | 5,714,285 | 05/10/2024 | 05/14/2024 | |
|
Gall Matthew
CFO |
Buy | 5,000 @ $8.37 | $41,850 | 19,429 | 10/12/2023 | 10/12/2023 | |
| Sell | 34,846 @ $14.19 | $494,465 | 2,119,212 | 08/23/2023 | 08/25/2023 | ||
| Sell | 95,516 @ $15.63 | $1.49 M | 2,023,696 | 08/23/2023 | 08/25/2023 | ||
| Sell | 219,638 @ $16.87 | $3.71 M | 1,804,058 | 08/23/2023 | 08/25/2023 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
iTeos Therapeutics, Inc. FAQ's
The list of insiders at iTeos Therapeutics, Inc. includes RA CAPITAL MANAGEMENT, L.P., Gall Matthew.
Insiders have purchased a total of 5.72 M iTeos Therapeutics, Inc. shares in the last 12 months for a total of 44,349.
The following insiders have purchased iTeos Therapeutics, Inc. shares in the last 12 months: RA CAPITAL MANAGEMENT, L.P. ($5,714), Gall Matthew ($38,635),